158 related articles for article (PubMed ID: 15757663)
1. Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.
Burger-Kentischer A; Finkelmeier D; Thiele M; Schmucker J; Geiger G; Tovar GE; Bernhagen J
FEBS Lett; 2005 Mar; 579(7):1693-701. PubMed ID: 15757663
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
Li Y; Lu C; Xing G; Zhu Y; He F
Exp Cell Res; 2004 Nov; 300(2):379-87. PubMed ID: 15475002
[TBL] [Abstract][Full Text] [Related]
3. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J
Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976
[TBL] [Abstract][Full Text] [Related]
4. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
[TBL] [Abstract][Full Text] [Related]
7. JAB1 enhances HAND2 transcriptional activity by regulating HAND2 DNA binding.
Dai YS; Hao J; Bonin C; Morikawa Y; Cserjesi P
J Neurosci Res; 2004 Jun; 76(5):613-22. PubMed ID: 15139020
[TBL] [Abstract][Full Text] [Related]
8. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.
Tanaka Y; Kanai F; Ichimura T; Tateishi K; Asaoka Y; Guleng B; Jazag A; Ohta M; Imamura J; Ikenoue T; Ijichi H; Kawabe T; Isobe T; Omata M
Oncogene; 2006 Jan; 25(4):633-42. PubMed ID: 16247477
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of the human Mov34 MPN domain reveals a metal-free dimer.
Sanches M; Alves BS; Zanchin NI; Guimarães BG
J Mol Biol; 2007 Jul; 370(5):846-55. PubMed ID: 17559875
[TBL] [Abstract][Full Text] [Related]
10. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1.
Cope GA; Suh GS; Aravind L; Schwarz SE; Zipursky SL; Koonin EV; Deshaies RJ
Science; 2002 Oct; 298(5593):608-11. PubMed ID: 12183637
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human ortholog of Mov34 reveals eight N-terminal residues important for MPN domain stability.
Alves BS; Oyama S; Gozzo FC; Sanches M; Guimarães BG; Zanchin NI
Biochem Biophys Res Commun; 2006 Sep; 347(3):608-15. PubMed ID: 16842755
[TBL] [Abstract][Full Text] [Related]
12. CSN5/Jab1 controls multiple events in the mammalian cell cycle.
Yoshida A; Yoneda-Kato N; Panattoni M; Pardi R; Kato JY
FEBS Lett; 2010 Nov; 584(22):4545-52. PubMed ID: 20974137
[TBL] [Abstract][Full Text] [Related]
13. Structure of the Jab1/MPN domain and its implications for proteasome function.
Tran HJ; Allen MD; Löwe J; Bycroft M
Biochemistry; 2003 Oct; 42(39):11460-5. PubMed ID: 14516197
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor does not modulate co-activation of androgen receptor by Jab1/CSN5.
Berndt K; Kim M; Meinhardt A; Klug J
Mol Cell Biochem; 2008 Jan; 307(1-2):265-71. PubMed ID: 17786542
[TBL] [Abstract][Full Text] [Related]
15. Intracellular interaction of myosin light chain kinase with macrophage migration inhibition factor (MIF) in endothelium.
Wadgaonkar R; Dudek SM; Zaiman AL; Linz-McGillem L; Verin AD; Nurmukhambetova S; Romer LH; Garcia JG
J Cell Biochem; 2005 Jul; 95(4):849-58. PubMed ID: 15838879
[TBL] [Abstract][Full Text] [Related]
16. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity.
Wang H; Sun X; Luo Y; Lin Z; Wu J
FEBS Lett; 2006 Oct; 580(25):6015-21. PubMed ID: 17052710
[TBL] [Abstract][Full Text] [Related]
17. Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5.
Yun J; Tomida A; Andoh T; Tsuruo T
J Biol Chem; 2004 Jul; 279(30):31296-303. PubMed ID: 15126503
[TBL] [Abstract][Full Text] [Related]
18. JAB1/CSN5 interacts with the GAL4 DNA binding domain: a note of caution about two-hybrid interactions.
Nordgård O; Dahle Ø; Andersen TØ; Gabrielsen OS
Biochimie; 2001 Oct; 83(10):969-71. PubMed ID: 11728635
[TBL] [Abstract][Full Text] [Related]
19. Domain architecture of the p62 subunit from the human transcription/repair factor TFIIH deduced by limited proteolysis and mass spectrometry analysis.
Jawhari A; Boussert S; Lamour V; Atkinson RA; Kieffer B; Poch O; Potier N; van Dorsselaer A; Moras D; Poterszman A
Biochemistry; 2004 Nov; 43(45):14420-30. PubMed ID: 15533047
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the human CSN6 MPN domain.
Ma XL; Xu M; Jiang T
Biochem Biophys Res Commun; 2014 Oct; 453(1):25-30. PubMed ID: 25242525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
